Clinical Trials · NCT00051558
Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 428
- Start date
- Nov 2002
- Locations
- 15 sites, 6 countries
- Primary endpoint
- Change From Baseline at 18 Month Endpoint in Lumbar Spine Bone Mineral Density (BMD)